Skip to main content
. 2021 Nov 11;13:186. doi: 10.1186/s13195-021-00927-z

Fig. 1.

Fig. 1

AD drugs in development, preclinical vs clinical. The number of drugs per target class in preclinical development is shown as a percentage of all drugs in preclinical development, and the number of drugs per target class in clinical development is shown as a percentage of all drugs in clinical development